Therefore, this meta-analysis aimed to address such gaps by systematically analysing and synthesizing existing data on the association between plasma klotho levels and a range of prognostic outcomes, including all-cause mortality, cardiovascular mortality, cardiovascular events, developing metabolic syndrome, adverse renal events including CKD progression, development of ESKD and initiation of renal replacement therapies. The gene discussed is KL; the disease is metabolic syndrome.